WSFS
ADMA icon

Wilmington Savings Fund Society’s ADMA Biologics ADMA Stock Holding History

Wilmington Savings Fund Society’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-110
Closed -$991 – 1488
2026
Q1 		$991 Sell
110
-275
-71% -$4.34K ﹤0.01% 1391
2025
Q4 		$7.02K Hold
385
– – ﹤0.01% 1218
2025
Q3 		$5.64K Buy
385
+339
+737% +$5.81K ﹤0.01% 1234
2025
Q2 		$838 Buy
+46
New +$938 ﹤0.01% 1977

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Wilmington Savings Fund Society's ADMA Position: Q2 2026 in Review

Wilmington Savings Fund Society sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 110 shares — an estimated $991 sold.

Wilmington Savings Fund Society first reported a position in ADMA in Q2 2025 and held it in 4 quarters. The position peaked at $7.02K in Q4 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Wilmington Savings Fund Society reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 110 ADMA Biologics shares in Q2 2026, an estimated $991.
  • Wilmington Savings Fund Society first reported a position in ADMA Biologics in Q2 2025 and held it in 4 quarters.
  • Wilmington Savings Fund Society's ADMA Biologics position peaked at $7.02K in Q4 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.